Alnylam Pharmaceuticals (ALNY) Equity Income (2009 - 2012)
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) Equity Income (2009 - 2012) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 4.08 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Incyte | 25.44 Bn | 20.91 Bn | 1.57 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2012 | -881,000.00 |
| Sep 30, 2012 | -1.61 Mn |
| Jun 30, 2012 | -1.14 Mn |
| Mar 31, 2012 | -889,000.00 |
| Dec 31, 2011 | -954,000.00 |
| Sep 30, 2011 | -467,000.00 |
| Jun 30, 2011 | -1.01 Mn |
| Mar 31, 2011 | -1.07 Mn |
| Dec 31, 2010 | -916,000.00 |
| Sep 30, 2010 | -1.23 Mn |
| Jun 30, 2010 | -3.92 Mn |
| Mar 31, 2010 | -1.58 Mn |
| Dec 31, 2009 | -1.49 Mn |
| Sep 30, 2009 | -1.14 Mn |
| Jun 30, 2009 | -816,000.00 |